Literature DB >> 17651232

The safety and efficacy of dressings with silver - addressing clinical concerns.

Keith Cutting1, Richard White, Mike Edmonds.   

Abstract

With the increasing use of silver as a topical application in wound care, concerns focussing on its role are bound to arise. These concerns, which centre on issues such as resistance and toxicity, clinical efficacy and cost-effectiveness, need to be addressed and openly discussed so that they are viewed from a rational perspective. While clinical efficacy and safety, along with cost-benefit, are of obvious interest, the origin of some of these concerns is a matter of debate. The silver-containing dressing segment of the medical device market is of huge commercial importance, and, consequently, marketing and promotional issues occasionally obscure the evidence that clinicians need to have in order that they may provide appropriate treatment for their patients. The impact of silver application on the wound bioburden needs to be examined carefully to heighten our awareness of any deleterious effects on the healing process, without inducing any unfounded anxieties.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17651232      PMCID: PMC7951405          DOI: 10.1111/j.1742-481X.2007.00338.x

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  47 in total

1.  Sustained silver-releasing dressing in the treatment of diabetic foot ulcers.

Authors:  G Rayman; A Rayman; N R Baker; N Jurgeviciene; V Dargis; R Sulcaite; O Pantelejeva; K G Harding; P Price; M Lohmann; J K Thomsen; P Gad; F Gottrup
Journal:  Br J Nurs       Date:  2005 Jan 27-Feb 9

Review 2.  Silver: clarifying the claims.

Authors:  David Parsons; Michael Walker; Philip G Bowler
Journal:  Ostomy Wound Manage       Date:  2006-06       Impact factor: 2.629

3.  Periplasmic metal-resistance protein CusF exhibits high affinity and specificity for both CuI and AgI.

Authors:  Joshua T Kittleson; Isabell R Loftin; Andrew C Hausrath; Kevin P Engelhardt; Christopher Rensing; Megan M McEvoy
Journal:  Biochemistry       Date:  2006-09-19       Impact factor: 3.162

Review 4.  A discussion of silver as an antimicrobial agent: alleviating the confusion.

Authors:  David W Brett
Journal:  Ostomy Wound Manage       Date:  2006-01       Impact factor: 2.629

Review 5.  A bacterial view of the periodic table: genes and proteins for toxic inorganic ions.

Authors:  Simon Silver; Le T Phung
Journal:  J Ind Microbiol Biotechnol       Date:  2005-10-12       Impact factor: 3.346

Review 6.  Topical agents in burn and wound care.

Authors:  R S Ward; J R Saffle
Journal:  Phys Ther       Date:  1995-06

7.  Measurement of cytoplasmic copper, silver, and gold with a lux biosensor shows copper and silver, but not gold, efflux by the CopA ATPase of Escherichia coli.

Authors:  Jivko V Stoyanov; David Magnani; Marc Solioz
Journal:  FEBS Lett       Date:  2003-07-10       Impact factor: 4.124

8.  Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment.

Authors:  J B Wright; K Lam; R E Burrell
Journal:  Am J Infect Control       Date:  1998-12       Impact factor: 2.918

9.  Properties of silver sulfadiazine-resistant Enterobacter cloacae.

Authors:  H S Rosenkranz; J E Coward; T J Wlodkowski; H S Carr
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

10.  Determination of silver in blood, urine, and tissues of volunteers and burn patients.

Authors:  A T Wan; R A Conyers; C J Coombs; J P Masterton
Journal:  Clin Chem       Date:  1991-10       Impact factor: 8.327

View more
  15 in total

1.  Topical Antimicrobials in Burn Care: Part 1-Topical Antiseptics.

Authors:  Janos Cambiaso-Daniel; Stafanos Boukovalas; Genevieve H Bitz; Ludwik K Branski; David N Herndon; Derek M Culnan
Journal:  Ann Plast Surg       Date:  2018-01-09       Impact factor: 1.539

2.  Topical silver-impregnated dressings and the importance of the dressing technology.

Authors:  Keith Cutting; Richard White; Hans Hoekstra
Journal:  Int Wound J       Date:  2009-10       Impact factor: 3.315

3.  The safety and efficacy of dressings with silver - addressing clinical concerns.

Authors:  B S Atiyeh; S N Hayek
Journal:  Int Wound J       Date:  2007-09       Impact factor: 3.315

4.  Local Probiotic Therapy with Lactobacillus plantarum Mitigates Scar Formation in Rabbits after Burn Injury and Infection.

Authors:  Latha Satish; Phillip H Gallo; Sandra Johnson; Cecelia C Yates; Sandeep Kathju
Journal:  Surg Infect (Larchmt)       Date:  2016-10-27       Impact factor: 2.150

5.  Wound bed preparation and oxygen balance--a new component?

Authors:  R Gary Sibbald; Kevin Y Woo; Douglas Queen
Journal:  Int Wound J       Date:  2007-09       Impact factor: 3.315

6.  Clinical efficacy of a silver-releasing foam dressing in venous leg ulcer healing: a randomised controlled trial.

Authors:  Patricia Senet; Renzo Bause; Bo Jørgensen; Karsten Fogh
Journal:  Int Wound J       Date:  2013-02-04       Impact factor: 3.315

7.  Essential oils and metal ions as alternative antimicrobial agents: a focus on tea tree oil and silver.

Authors:  Wan-Li Low; Ken Kenward; Stephen T Britland; Mohd Cim Amin; Claire Martin
Journal:  Int Wound J       Date:  2016-05-05       Impact factor: 3.315

8.  Unilateral Silver-Loaded Silk Fibroin Difunctional Membranes as Antibacterial Wound Dressings.

Authors:  Jinlong Shao; Yating Cui; Ye Liang; Hong Liu; Baojin Ma; Shaohua Ge
Journal:  ACS Omega       Date:  2021-06-30

9.  Active silver nanoparticles for wound healing.

Authors:  Chiara Rigo; Letizia Ferroni; Ilaria Tocco; Marco Roman; Ivan Munivrana; Chiara Gardin; Warren R L Cairns; Vincenzo Vindigni; Bruno Azzena; Carlo Barbante; Barbara Zavan
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

10.  The use of biatain Ag in hard-to-heal venous leg ulcers: meta-analysis of randomised controlled trials.

Authors:  David Leaper; Christian Münter; Sylvie Meaume; Alessandro Scalise; Nacho Blanes Mompó; Birte Petersen Jakobsen; Finn Gottrup
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.